$AMLX
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Joshua Cohen
CEO
123
Employees
$13.68
Current Price
$1.17B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 1 | 1 | $51,338.00 | 3,800 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 1 | 1 | $51,338.00 | 3,800 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 1 | 1 | $51,338.00 | 3,800 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 1 | 1 | $51,338.00 | 3,800 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 21, 2026 | Firestone Karen Director | Purchase | 3,800 | $13.51 | $51,338.00 | View Details |
| Mar 2, 2026 | Klee Justin B. Director | Sale | 29,282 | $14.47 | $423,760.32 | View Details |
| Mar 2, 2026 | Cohen Joshua B Director | Sale | 29,282 | $14.48 | $424,120.49 | View Details |
| Mar 2, 2026 | Bedrosian Camille L Chief Medical Officer | Sale | 6,461 | $14.58 | $94,205.26 | View Details |
| Mar 2, 2026 | FRATES JAMES M Chief Financial Officer | Sale | 7,909 | $14.52 | $114,851.33 | View Details |
| Mar 2, 2026 | Mazzariello Gina Chief Legal Officer | Sale | 6,844 | $14.52 | $99,378.30 | View Details |
23 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.30
ActualN/A
Revenue
EstimatedN/A
ActualN/A
2 more earnings records available โ create a free account to see 12 months of history
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: